Retina specialists are shifting from povidone iodine to chlorhexidine to prevent infections after eye injections. A new study ...

Introduction Shared decision-making (SDM) requires that individuals are correctly and smoothly supported to make decisions. However, in Japan, development of decision aids (DAs) to support ...

In the phase 1 portion of the trial, two doses of gedatolisib were administered IV on an intermittent schedule (Days 1, 8, 15 ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ankyra Therapeutics, a clinical-stage oncology company developing anchored immunotherapies to improve the therapeutic window for immuno-oncology drugs, announced ...

List of terms commonly used in clinical trial research. Glossary of Medical Terms in Lay Language Helpful list of medical terms described in lay language. Sample Study Startup Checklist Use this ...

A protocol deviation or violation is any departure from the study procedures or treatment plans as specified in the IRB-approved protocol. Protocol deviations occur when an investigator does not ...

A presentation slated to be shared at this week’s meeting of vaccine advisers to the US Centers for Disease Control and Prevention claimed that a study in animals suggested that use of the vaccine ...

Please provide your email address to receive an email when new articles are posted on . The NEW DAY study did not meet its primary endpoint but showed good outcomes in secondary endpoints. A post hoc ...

PRAGUE, Czechia—Current European Society of Cardiology (ESC) heart failure guidelines stipulate that a urinary sodium-guided approach is best for dosing diuretics in acute congestion, but many centers ...

UConn Health has acknowledged that it had a lapse in an approved research protocol involving use of animals in the research process and that it was reported to federal regulators. A spokeswoman for ...

Follow the step-by-step instructions below to successfully maintain and close a protocol with the IRB. Instructions below include information about continuing reviews, amendments, event reporting (new ...

PHILADELPHIA--(BUSINESS WIRE)--iECURE, Inc., a gene editing company focused on the development of mutation-agnostic in vivo gene insertion therapies for the treatment of liver disorders with ...